Prediction: Pfizer Stock Could Double If Pipeline Delivers
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Summarize the 2023 performance of World Ex Us dividend ETFs, highlighting key drivers, top contributors, and implications for investors.
22,394 articlesPfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Warren Buffett hands the CEO role to Greg Abel, shifting Berkshire Hathaway's guard and fueling a debate about whethe...
A monthly dividend growth fund has outperformed SCHD by 38 percentage points over the past decade, challenging the tr...
Geopolitical risk in the Middle East is reshaping energy markets. Five high-yield energy stocks offer robust dividend...
CryptoQuant urges Strategy to pause BTC purchases amid cash strain and ballooning dividends, signaling a potential sh...
Tariff headlines keep markets guessing. This guide shows how two Vanguard index funds outperformed the S&P 500 in 202...
The chip sector faced a sharp setback as AI-driven momentum cooled and investors booked profits. This guide explains ...
U.S. corporations are accelerating stock repurchases, widening participation beyond mega-cap tech and triggering a br...
Tesla commands a large slug of XLY, giving the fund a distinct risk/reward profile compared with VCR. In the past fiv...
Two popular short-term bond ETFs—VCSH and ISTB—offer different paths to steady income. This guide breaks down cost, r...
Global markets aren’t just a backdrop to the US story. Three practical tailwinds could lift international stocks for ...
When the world's wealthiest fund managers move, markets listen. This deep dive explains how the latest 13F season sho...